concerning vaso - i am a very long term holder (started buying after the crash/fallout from the PEECH trials). i am cautiously bullish. i think the long term risk/reward is very solid here and was further bolstered by extension of the GEHC agreement. long term they need to exponentially ramp up top and bottom line growth on the equipment side.
they REALLY need to provide a more specific plan to investors on the efforts of the consultants on CMS reimbursement (both expanded and specific improved) and provide objective milestones. investors have a substantial stake in the dilution based on these efforts. however, the company did sustantially backload the dilution so 91-92% of it doesnt occur unless there are results. so far - this has not happened. their last newsletter published on the website made weak mention of the efforts but the shareholders deserve/are entitled to more (yes - when you buy shares you do become entitled to certain fiduciary updates.)
i have been an active buyer when it drops out of the current trading range ($0.22-0.24) and goes to $0.18-0.20. right now, there still seems to be an endless supply of shares available and only sustained improvements on the equipment side seem to provide the impetus to really move the stock forward and keep it there. i am still expecting a run similar to last year when there was a lot of shares trading hands with no price movement and then boom - ran to $0.74. considering the company is in MUCH better shape now than then, the chances of a similar run are high. however, a lot of bagholders from the last run will be looking for exit points and will limit it (assuming the run is on no news and out of the blue like last time).
i will continue to follow this board. i still post on yahoo and RB but not frequently.
Recent VASO News
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/10/2024 09:08:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 09:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/23/2024 08:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 08:01:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:00:52 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 08/02/2024 05:47:51 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 07/26/2024 01:37:49 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:01:18 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 03/06/2024 09:58:30 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 12/11/2023 07:10:05 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM